CYDY is likely to have a specific situation that will have an approved drug for HIV-1 in the next 5-6 months, and by that time it will prove to be very effective in metastatic cancers, the NP said 22 cancers. If people start to use it off-label massively, the FDA will have to act. The FDA has approved some cancers drugs with less than 100 patients tested, and Leronlimab has been tested on over 830 patients.